- Home
- Publications
- Publication Search
- Publication Details
Title
The chemical biology of NAD+ regulation in axon degeneration
Authors
Keywords
-
Journal
CURRENT OPINION IN CHEMICAL BIOLOGY
Volume 69, Issue -, Pages 102176
Publisher
Elsevier BV
Online
2022-07-01
DOI
10.1016/j.cbpa.2022.102176
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients
- (2022) A. Joseph Bloom et al. Molecular Neurodegeneration
- Pathogen infection and cholesterol deficiency activate the C. elegans p38 immune pathway through a TIR-1/SARM1 phase transition
- (2022) Nicholas D Peterson et al. eLife
- SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites
- (2022) Carlo Angeletti et al. iScience
- Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules
- (2022) Yun Shi et al. MOLECULAR CELL
- Small Molecule SARM1 Inhibitors Recapitulate the SARM1−/− Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate
- (2021) Robert O. Hughes et al. Cell Reports
- SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration
- (2021) Matthew D. Figley et al. NEURON
- Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy
- (2021) Todd Bosanac et al. BRAIN
- Acidic pH irreversibly activates the signaling enzyme SARM1
- (2021) Yong Juan Zhao et al. FEBS Journal
- A phase transition enhances the catalytic activity of SARM1, an NAD+ glycohydrolase involved in neurodegeneration
- (2021) Heather S Loring et al. eLife
- A Novel NAD Signaling Mechanism in Axon Degeneration and its Relationship to Innate Immunity
- (2021) Eleanor L. Hopkins et al. Frontiers in Molecular Biosciences
- Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection
- (2021) Yo Sasaki et al. EXPERIMENTAL NEUROLOGY
- Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders
- (2021) Jonathan Gilley et al. eLife
- Initial Kinetic Characterization of Sterile Alpha and Toll/Interleukin Receptor Motif-Containing Protein 1
- (2020) Heather S. Loring et al. BIOCHEMISTRY
- Sarm1 loss reduces axonal damage and improves cognitive outcome after repetitive mild closed head injury
- (2020) Mark E. Maynard et al. EXPERIMENTAL NEUROLOGY
- Programmed axon degeneration: from mouse to mechanism to medicine
- (2020) Michael P. Coleman et al. NATURE REVIEWS NEUROSCIENCE
- SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration
- (2020) Kwang Woo Ko et al. JOURNAL OF CELL BIOLOGY
- Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1
- (2020) Matthew Bratkowski et al. Cell Reports
- Identification of the first noncompetitive SARM1 inhibitors
- (2020) Heather S. Loring et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The NAD+-mediated self-inhibition mechanism of pro-neurodegenerative Sarm1
- (2020) Yuefeng Jiang et al. NATURE
- Structural Evidence for an Octameric Ring Arrangement of SARM1
- (2019) Michael Sporny et al. JOURNAL OF MOLECULAR BIOLOGY
- Sarm1 Gene Deficiency Attenuates Diabetic Peripheral Neuropathy in Mice
- (2019) Yalan Cheng et al. DIABETES
- NAD+ in Brain Aging and Neurodegenerative Disorders
- (2019) Sofie Lautrup et al. Cell Metabolism
- Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury
- (2018) Kimberly A. Fernandes et al. EXPERIMENTAL EYE RESEARCH
- The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD + Cleavage Activity that Promotes Pathological Axonal Degeneration
- (2017) Kow Essuman et al. NEURON
- Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice
- (2016) Stefanie Geisler et al. BRAIN
- Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lackingSarm1
- (2016) Nils Henninger et al. BRAIN
- NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
- (2015) Carles Cantó et al. Cell Metabolism
- SARM1 activation triggers axon degeneration locally via NAD+ destruction
- (2015) J. Gerdts et al. SCIENCE
- Calcium Release from Intra-Axonal Endoplasmic Reticulum Leads to Axon Degeneration through Mitochondrial Dysfunction
- (2014) R. Villegas et al. JOURNAL OF NEUROSCIENCE
- Metabolic Profiling of Alternative NAD Biosynthetic Routes in Mouse Tissues
- (2014) Valerio Mori et al. PLoS One
- Sarm1-Mediated Axon Degeneration Requires Both SAM and TIR Interactions
- (2013) J. Gerdts et al. JOURNAL OF NEUROSCIENCE
- dSarm/Sarm1 Is Required for Activation of an Injury-Induced Axon Death Pathway
- (2012) J. M. Osterloh et al. SCIENCE
- Two-pore channels: Regulation by NAADP and customized roles in triggering calcium signals
- (2010) Sandip Patel et al. CELL CALCIUM
- NAADP mobilizes calcium from acidic organelles through two-pore channels
- (2009) Peter J. Calcraft et al. NATURE
- Covalent and Noncovalent Intermediates of an NAD Utilizing Enzyme, Human CD38
- (2008) Qun Liu et al. CHEMISTRY & BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started